A fatal case of enoxaparin induced skin necrosis and thrombophilia

European Journal of Haematology

Volumn 77, Issue 2, 2006, Pages 166-168

  Nadir, Yona ^a   Mazor, Yoav ^a   Reuven, Bergman ^a   Sarig, Galit ^a   Brenner, Benjamin ^a   Krivoy, Norberto ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Enoxaparin; Skin necrosis; Thrombophilia

Indexed keywords

ENOXAPARIN; HEPARIN DERIVATIVE; PHOSPHOLIPID ANTIBODY;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; DISEASE EXACERBATION; DISSEMINATED INTRAVASCULAR CLOTTING; FATALITY; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; SKIN DEFECT; SKIN NECROSIS; THROMBOPHILIA; VITAMIN K DEFICIENCY;

AGED; ANTICOAGULANTS; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; ENOXAPARIN; FACTOR V; FACTOR VIII; FATAL OUTCOME; FEMALE; FRACTURES, BONE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NECROSIS; POSTOPERATIVE COMPLICATIONS; PROTHROMBIN; THROMBOEMBOLISM; THROMBOPHILIA;

EID: 33745727586     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2006.00668.x     Document Type: Article

References (11)

1. BURK III RW, SERAFIN D, KLITZMAN B. Toxic effects of catecholamines on skin. Plast Reconstr Surg 1990;85:92-99.
2. SUBHANI M, SRIDHAR S, DECRISTOFARO JD. Phentolamine use in a neonate for the prevention of dermal necrosis caused by dopamine: a case report. J Perinatol 2001;21:324-326.
3. VIGANO D'ANGELO S, COMP PC, ESMON CT, D'ANGELO A. Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states. J Clin Invest 1986;77:416-425.
4. ANG KL, BOSE A, HALIL O, CUMMINS D, AMRANI M. Low molecular weight heparin (LMWH)-induced skin necrosis in a patient with unstable angina. Int J Cardiol 2003;91:239-240.
5. BALESTRA B, QUADRI P, DERMARMELS BIASIUTTI F, FURLAN M, LAMMLE B. Low molecular weight heparin-induced thrombocytopenia and skin necrosis distant from injection sites. Eur J Haematol 1994;53:61-63.
6. TIETGE UJ, SCHMIDT HH, JACKEL E, TRAUTWEIN C, MANNS MP. Low molecular weight heparin-induced skin necrosis occurring distant from injection sites and without thrombocytopenia. J Intern Med 1998;243:313-315.
7. TONN ME, SCHAIFF RA, KOLLEF MH. Enoxaparin-associated dermal necrosis: a consequence of cross-reactivity with heparin-mediated antibodies. Ann Pharmacother 1997;31:323-326.
8. PLATH J, SCHULZE R, BARZ D, KRAMMER B, STEINER M, ANDERS O, MACH J. Necrotizing skin lesions induced by low-molecular-weight heparin after total knee arthroplasty. Arch Orthop Trauma Surg 1997;116:443-445.
9. WARKENTIN TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 2003;121:535-555 (review).
10. WARKENTIN TE, WHITLOCK RP, TEOH KH. Warfarin-associated multiple digital necrosis complicating heparin-induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma-associated thrombotic endocarditis. Am J Hematol 2004;75:56-562.
11. HANDSCHIN AE, TRENTZ O, KOCK HJ, WANNER GA. Low molecular weight heparin-induced skin necrosis-a systematic review. Langenbecks Arch Surg 2005;390:249-254.